CBIZ Investment Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109K Sell
502
-629
-56% -$140K ﹤0.01% 57
2025
Q4
$258K Buy
1,131
+111
+11% +$25.3K 0.01% 48
2025
Q3
$236K Buy
1,020
+94
+10% +$19.1K 0.01% 48
2025
Q2
$172K Sell
926
-80
-8% -$14.9K 0.01% 54
2025
Q1
$211K Buy
1,006
+79
+9% +$15.4K 0.01% 52
2024
Q4
$165K Sell
927
-21
-2% -$3.86K 0.01% 57
2024
Q3
$187K Buy
948
+152
+19% +$28.4K 0.01% 51
2024
Q2
$137K Sell
796
-89
-10% -$14.7K 0.01% 57
2024
Q1
$161K Buy
+885
New +$153K 0.01% 51
2020
Q3
Hold
0
68
2020
Q2
Hold
0
75
2020
Q1
Hold
0
74
2019
Q4
Hold
0
81

Other funds holding ABBV

CBIZ Investment Advisory Services's ABBV Position: Q1 2026 in Review

CBIZ Investment Advisory Services reduced its AbbVie (ABBV) stake by 56% in Q1 2026, selling an estimated $140K and leaving 502 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #57.

CBIZ Investment Advisory Services first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $258K in Q4 2025. 4,074 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • CBIZ Investment Advisory Services held 502 shares of AbbVie worth $109K as of Q1 2026.
  • CBIZ Investment Advisory Services sold 629 AbbVie shares in Q1 2026, an estimated $140K.
  • AbbVie made up ﹤0.01% of CBIZ Investment Advisory Services's portfolio in Q1 2026, its #57 holding.
  • CBIZ Investment Advisory Services first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • CBIZ Investment Advisory Services's AbbVie position peaked at $258K in Q4 2025.
  • 4,074 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.